Type
1.
Scheving, Kanabrocki, Tsai, Pauly. Circadian and other variation in epinephrine and norepinephrine among several human populations, including healthy blinded and sighted subjects and patients with leprosy. Progress in clinical and biological research. 1987;227A:329-49.
Type
1.
Heldt. Public health ophthalmology: a comprehensive model for the prevention of blindness in developing nations. Ophthalmic surgery. 1987;18(11):835-9.
Type
1.
Hargrave. Problems of leprosy reconstructive surgery in Australia. The Medical journal of Australia. 1972;2(15):843-5.
Type
1.
Choyce. Kerato-uveal changes in leprosy and onchocerciasis: a question of immunity. Proceedings of the Royal Society of Medicine. 1972;65(11):955-60.
Type
1.
HOBBS. Leprotic iritis and blindness. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association [Internet]. 1972;40(4):366-74. Available from: http://ila.ilsl.br/pdfs/v40n4a03.pdf
Type
1.
PRASAD. Epidemiological research and its impact on health and medical care. The Indian journal of medical research. 1972;60(4):501-11.
Type
1.
Choyce. Blindness in leprosy. Tropical doctor. 1973;3(1):16-9.
Type
1.
Enna, Delgado. Surgical correction of common facial deformities due to leprosy. Plastic and reconstructive surgery. 1968;42(5):422-32.
Type
1.
Weerekoon. Ocular leprosy in West Malaysia. Search for a posterior segment lesion. The British journal of ophthalmology. 1972;56(2):106-13.
Type
1.
HOBBS, Choyce. The binding lesions of leprosy. Leprosy review [Internet]. 1971;42(2):131-7. Available from: http://leprev.ilsl.br/pdfs/1971/v42n2/pdf/v42n2a11.pdf
Pagination
- Previous page
- Page 7
- Next page